Total Funding
47
53
Total FundingPost-IPO Equity raised
Growth Score 47 in past quarter
-9 pts
Heat Score 53 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
208457
Synbio Technologies offers molecular biology services, recombinant protein expression services, and antibody engineering services.
- Ping Yang: Founder & CEOPast Role: GenScript, Gene Department Associate Director
About the Company
Synbio Technologies provides hybridoma antibody gene sequencing, immune repertoire sequencing, antibody design, antibody humanization, monoclonal antibody preparation, polyclonal antibody preparation, preparation of recombinant engineering antibodies, stable cell line construction, plasmid preparation, and point mutation.